CNBG · ToCell
Supporting China's Biopharmaceutical Process Engineering Technology
CNBG ToCell (Wuxi) Biotechnology Co., Ltd., a subsidiary of China National Biotec Group (CNBG) under the SINOPHARM, is a leading provider of advanced biopharmaceutical process technologies and solutions in China. We are committed to strengthening independent control over upstream raw materials and equipment in China’s biopharmaceutical industry, accelerating the industry’s growth and development. We focus on customized cell culture medium and paper-based carrier research and production, large-scale bioreactor design and manufacturing, animal cell culture technology, and bioprocess technology development and transfer, forming the foundation of a robust biopharmaceutical process technology platform.
Be established in
Patent technology
Annual capacity
Annual output
Official account
Wuxi Address: 699 Zhide Avenue, Xinwu District, Wuxi City
Suzhou Address: Entrance A, 1F, Zhanhua Science and Technology Building, No. 8 Pangyang Road, Wujiang District, Suzhou City, Jiangsu Province
Copyright：© 2025 CNBG ToCell (Wuxi) Biotechnology Co., Ltd. Powered by：www.300.cn SEO